In vivo therapeutic intervention using engineered PSAP and GPR37 gene‐editing virus‐loaded hydrogels demonstrated significant improvements in disc structural integrity and matrix composition in preclinical IDD models, with these protective effects being dependent on GPR37 receptor activation. This evidence concerns the gene GPR37 and intervertebral disk degenerative disorder.